1-204944400-A-G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS1

The NM_001005388.3(NFASC):​c.85A>G​(p.Met29Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000125 in 1,361,188 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0000071 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000013 ( 0 hom. )

Consequence

NFASC
NM_001005388.3 missense

Scores

6
12

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 2.64

Publications

1 publications found
Variant links:
Genes affected
NFASC (HGNC:29866): (neurofascin) This gene encodes an L1 family immunoglobulin cell adhesion molecule with multiple IGcam and fibronectin domains. The protein functions in neurite outgrowth, neurite fasciculation, and organization of the axon initial segment (AIS) and nodes of Ranvier on axons during early development. Both the AIS and nodes of Ranvier contain high densities of voltage-gated Na+ (Nav) channels which are clustered by interactions with cytoskeletal and scaffolding proteins including this protein, gliomedin, ankyrin 3 (ankyrin-G), and betaIV spectrin. This protein links the AIS extracellular matrix to the intracellular cytoskeleton. This gene undergoes extensive alternative splicing, and the full-length nature of some variants has not been determined.[provided by RefSeq, May 2009]
NFASC Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with central and peripheral motor dysfunction
    Inheritance: AR, AD Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.09210318).
BP6
Variant 1-204944400-A-G is Benign according to our data. Variant chr1-204944400-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 2535566.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAdExome4 allele frequency = 0.0000131 (16/1220260) while in subpopulation EAS AF = 0.000715 (13/18180). AF 95% confidence interval is 0.000422. There are 0 homozygotes in GnomAdExome4. There are 11 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NFASCNM_001005388.3 linkc.85A>G p.Met29Val missense_variant Exon 3 of 30 ENST00000339876.11 NP_001005388.2 O94856-9
NFASCNM_001160331.2 linkc.85A>G p.Met29Val missense_variant Exon 2 of 28 ENST00000539706.6 NP_001153803.1 O94856-11

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NFASCENST00000339876.11 linkc.85A>G p.Met29Val missense_variant Exon 3 of 30 5 NM_001005388.3 ENSP00000344786.6 O94856-9
NFASCENST00000539706.6 linkc.85A>G p.Met29Val missense_variant Exon 2 of 28 5 NM_001160331.2 ENSP00000438614.2 O94856-11

Frequencies

GnomAD3 genomes
AF:
0.00000710
AC:
1
AN:
140928
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000257
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000498
AC:
12
AN:
241080
AF XY:
0.0000764
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000677
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000131
AC:
16
AN:
1220260
Hom.:
0
Cov.:
32
AF XY:
0.0000182
AC XY:
11
AN XY:
603282
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26418
American (AMR)
AF:
0.00
AC:
0
AN:
35478
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
17054
East Asian (EAS)
AF:
0.000715
AC:
13
AN:
18180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83416
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33932
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4382
European-Non Finnish (NFE)
AF:
0.00000209
AC:
2
AN:
956802
Other (OTH)
AF:
0.0000224
AC:
1
AN:
44598
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000710
AC:
1
AN:
140928
Hom.:
0
Cov.:
32
AF XY:
0.0000147
AC XY:
1
AN XY:
68192
show subpopulations
African (AFR)
AF:
0.0000257
AC:
1
AN:
38984
American (AMR)
AF:
0.00
AC:
0
AN:
14286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3310
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4054
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3914
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8534
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
306
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
64674
Other (OTH)
AF:
0.00
AC:
0
AN:
2002
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
May 10, 2023
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.19
CADD
Uncertain
23
DANN
Uncertain
0.98
DEOGEN2
Benign
0.11
.;.;.;.;.;.;.;.;.;T
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.056
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.92
D;T;T;D;D;.;D;.;.;D
M_CAP
Benign
0.025
T
MetaRNN
Benign
0.092
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.63
T
MutationAssessor
Benign
0.34
N;N;N;N;N;N;.;N;N;.
PhyloP100
2.6
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-0.95
N;N;N;N;N;N;N;N;N;N
REVEL
Benign
0.081
Sift
Uncertain
0.0020
D;D;D;D;D;D;D;D;D;D
Sift4G
Uncertain
0.040
D;T;T;T;T;D;T;T;T;T
Polyphen
0.0090
B;B;B;B;.;B;.;B;B;.
Vest4
0.45
MutPred
0.24
Gain of sheet (P = 0.0827);Gain of sheet (P = 0.0827);Gain of sheet (P = 0.0827);Gain of sheet (P = 0.0827);Gain of sheet (P = 0.0827);Gain of sheet (P = 0.0827);Gain of sheet (P = 0.0827);Gain of sheet (P = 0.0827);Gain of sheet (P = 0.0827);.;
MVP
0.77
MPC
0.44
ClinPred
0.18
T
GERP RS
4.2
gMVP
0.36
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs763379325; hg19: chr1-204913528; API